Biophysical dissection of nociceptor hyperexcitability caused by a Nav1.8 gain-of-function mutation linked to severe pain

通过生物物理学方法剖析由 Nav1.8 功能获得性突变引起的伤害感受器过度兴奋,该突变与严重疼痛相关

阅读:1

Abstract

Voltage-gated sodium channel Nav1.8 is highly expressed in nociceptors, where it plays a critical role in sustaining repetitive action potential (AP) firing. Gain-of-function Nav1.8 mutations that increase nociceptor excitability have been identified in patients with painful peripheral neuropathy, but the biophysical mechanisms by which they confer nociceptor hyperexcitability are incompletely understood. Here we carry out a high-resolution dissection of the functional consequences of a Nav1.8 mutation (G1662S) identified in human subjects with severe neuropathic pain, using dynamic clamp modeling in small dorsal root ganglion (DRG) neurons. While Nav1.8WT/GS conductance did not alter resting membrane potential, rheobase, or single AP threshold, it produced a marked hyperexcitability during repetitive firing. Nav1.8WT/GS neurons generated nearly twice as many APs as wild-type controls in response to suprathreshold depolarization, an effect attributable to increased sodium charge transfer across successive spikes. Charge analysis revealed that the GS mutation disproportionately enhanced suprathreshold sodium influx, supporting greater AP fidelity without adaptation. Biophysical dissection showed that this excitability phenotype arises from frequency-dependent mechanisms: at lower firing frequencies, the depolarizing shift in steady-state inactivation increases channel availability and contributes to G1662S-mediated hyperexcitability, whereas at higher firing frequencies both the depolarized voltage-dependence of inactivation and the accelerated recovery from inactivation further sustain G1662S hyperexcitability. Together, these properties enable Nav1.8WT/GS neurons to maintain enhanced firing across a broad range of frequencies, in contrast to wild-type nociceptors that typically adapt faster. These findings provide mechanistic insight into Nav1.8-driven hyperexcitability and highlight Nav1.8 as a therapeutic target for genetic and acquired pain syndromes.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。